The COVID-19 MS Coalition-accelerating diagnostics, prognostics, and treatment

Affiliations

¹ Department of Chemistry and Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, UK.
² Centre for Proteome Research, Institute for Integrative Biology and Department of Biochemistry, University of Liverpool, Liverpool, UK.
³ Department of Chemistry and Surrey Ion Beam Centre, University of Surrey, Surrey, UK.
⁴ Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
⁵ Department of Pharmaceutical Chemistry & Bioanalytics, Institute of Pharmacy, Charles Tanford Protein Center, Martin-Luther University Halle-Wittenberg, Halle, Germany.
⁶ Proteomics Unit, Centro Nacional de Biotecnología, Madrid, Spain; ProteoRed-ISCIII, Madrid, Spain.
⁷ Institute of Structural and Molecular Biology, Department of Structural and Molecular Biology, University College London, London, UK.
⁸ National Measurement Laboratory, LGC, Teddington, Middlesex, UK.
⁹ Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Science Centre, Manchester, UK; Michael Barber Centre for Collaborative Mass Spectrometry, Manchester Institute of Biotechnology, University of Manchester, Manchester M1 7DN, UK.
¹⁰ Michael Barber Centre for Collaborative Mass Spectrometry, Manchester Institute of Biotechnology, University of Manchester, Manchester M1 7DN, UK; Department of Chemistry, University of Manchester, Manchester M1 7DN, UK. Electronic address: perdita.barran@manchester.ac.uk.

Weston Struwe et al. Lancet. 2020.

. 2020 Jun 6;395(10239):1761-1762.

doi: 10.1016/S0140-6736(20)31211-3. Epub 2020 May 27.

¹ Department of Chemistry and Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, UK.
² Centre for Proteome Research, Institute for Integrative Biology and Department of Biochemistry, University of Liverpool, Liverpool, UK.
³ Department of Chemistry and Surrey Ion Beam Centre, University of Surrey, Surrey, UK.
⁴ Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
⁵ Department of Pharmaceutical Chemistry & Bioanalytics, Institute of Pharmacy, Charles Tanford Protein Center, Martin-Luther University Halle-Wittenberg, Halle, Germany.
⁶ Proteomics Unit, Centro Nacional de Biotecnología, Madrid, Spain; ProteoRed-ISCIII, Madrid, Spain.
⁷ Institute of Structural and Molecular Biology, Department of Structural and Molecular Biology, University College London, London, UK.
⁸ National Measurement Laboratory, LGC, Teddington, Middlesex, UK.
⁹ Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Science Centre, Manchester, UK; Michael Barber Centre for Collaborative Mass Spectrometry, Manchester Institute of Biotechnology, University of Manchester, Manchester M1 7DN, UK.
¹⁰ Michael Barber Centre for Collaborative Mass Spectrometry, Manchester Institute of Biotechnology, University of Manchester, Manchester M1 7DN, UK; Department of Chemistry, University of Manchester, Manchester M1 7DN, UK. Electronic address: perdita.barran@manchester.ac.uk.

No abstract available

References

1. Amanat F, Stadlbauer D, Strohmeier S. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020 doi: 10.1038/s41591-020-0913-5. published online May 12. - DOI - PMC - PubMed
1. Wölfel R, Corman VM, Guggemos W. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020 doi: 10.1038/s41586-020-2196-x. published online April 1. - DOI - PubMed
1. Ihling C, Tänzler D, Hagemann S, Kehlen A, Hüttelmaier S, Sinz A. Mass spectrometric identification of SARS-CoV-2 proteins from gargle solution samples of COVID-19 patients. bioRxiv. 2020 doi: 10.1101/2020.04.18.047878. published online April 19. (preprint). - DOI - PubMed
1. Messner CB, Demichev V, Wendisch D. Clinical classifiers of COVID-19 infection from novel ultra-high-throughput proteomics. medRxiv. 2020 doi: 10.1101/2020.04.27.20081810. published online May 3. (preprint). - DOI - PMC - PubMed
1. Watanabe Y, Allen JD, Wrapp D, McLellan JS, Crispin M. Site-specific glycan analysis of the SARS-CoV-2 spike. bioRxiv. 2020 doi: 10.1126/science.abb9983. published online May 4. (preprint). - DOI - PMC - PubMed